Accumulating evidence on AD, PD, Huntington’s disease (HD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) have demonstrated that the loss of Nrf2 exacerbates neurodegenerative symptoms [83]. Here, NFE2L2 is linked to myeloid sarcoma.